Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck
Pharma
Merck touts newly approved Winrevair as example of BD acumen
Merck touted newly approved Winrevair and what the emergence of the potential blockbuster means for the company as it faces the Keytruda LOE.
Kevin Dunleavy
Apr 25, 2024 11:06am
Merck aims to 'outnumber' pulmonary arterial hypertension
Apr 16, 2024 10:37am
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am
Merck CEO Robert Davis receives 9% pay hike to $20.3M
Apr 12, 2024 10:27am
FDA signs off on Merck’s potential blockbuster Winrevair for PAH
Mar 26, 2024 5:11pm
FDA approves Johnson & Johnson's combo pill Opsynvi for PAH
Mar 25, 2024 11:05am